Uev1A Activators
Uev1A Activators are a diverse array of chemical compounds that indirectly enhance the functional activity of Uev1A by modulating specific signaling pathways and cellular processes. PMA, by activating PKC, promotes phosphorylation events within the NF-κB pathway, a signaling cascade that Uev1A is known to regulate, thus enhancing Uev1A's activity. Similarly, Forskolin, through the elevation of cAMP levels, indirectly augments Uev1A's role by activating PKA and influencing the endosomal sorting complex thatrequires Uev1A. Ionomycin's modulation of calcium levels can potentiate Uev1A's interaction with UEV proteins, critical for vesicular trafficking and DNA repair, while EGCG's kinase inhibition may relieve competition for Uev1A-dependent pathways. Inhibitors like LY294002 and Wortmannin target PI3K, shifting cellular signaling in favor of Uev1A's involvement in DNA damage response. SB203580 and U0126, by targeting p38 MAPK and MEK1/2, respectively, may also create a favorable environment for Uev1A's activity in stress response and cell cycle regulation.
The activity of Uev1A is further influenced by compounds that modulate various signaling molecules and pathways. Sphingosine-1-phosphate and Thapsigargin both work through lipid signaling and calcium homeostasis, respectively, to enhance Uev1A's role in intracellular trafficking. Staurosporine, despite its broad kinase inhibition profile, may selectively augment Uev1A's DNA damage response by reducing specific competing kinase activities. ZM-447439's inhibition of Aurora kinases could also favor Uev1A's role in cell cycle checkpoint control and DNA repair mechanisms. Collectively, these Uev1A Activators, through their targeted effects on cellular signaling, serve to enhance the functional activity of Uev1A, emphasizing its critical role in various cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates Protein Kinase C (PKC), which can phosphorylate proteins involved in the NF-κB pathway. Uev1A, as a part of the ubiquitin-conjugating enzyme complex, is implicated in the regulation of NF-κB signaling, and PKC-mediated activation of this pathway can lead to enhanced activity of Uev1A. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases intracellular cAMP levels, which activates PKA. PKA phosphorylates several targets that may enhance the assembly and activity of the Uev1A-UEV/TSG101 complex involved in endosomal sorting. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that elevates intracellular calcium levels, stimulating calcium-dependent signaling pathways. Increased intracellular calcium can enhance the interaction of Uev1A with other UEV proteins, which are crucial for vesicular trafficking and DNA repair processes. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits several kinases, potentially reducing competitive signaling and allowing for the upregulation of pathways where Uev1A is active, particularly in DNA damage response and repair mechanisms. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter signaling pathways downstream of PI3K, including those related to cell survival and DNA damage response. By inhibiting PI3K, LY294002 can potentiate pathways in which Uev1A is involved, specifically those related to the cellular response to DNA damage. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. By inhibiting p38 MAPK, it may shift signaling towards pathways that involve Uev1A in the cellular response to stress and DNA damage. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
D-erythro-Sphingosine-1-phosphate activates sphingosine-1-phosphate receptors, which can lead to the activation of signaling pathways that intersect with those regulated by Uev1A, particularly in endocytic trafficking. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium levels. Elevated calcium may enhance Uev1A activity in pathways related to intracellular trafficking and signaling. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor. By inhibiting certain kinases, it can indirectly enhance Uev1A's functional role in DNA damage response by reducing competitive kinase activity. | ||||||